Ibuprofen 200Mg Oral Tablet

DRUG2 trials

Sponsors

Reckitt Benckiser Healthcare (UK) Limited, State University of New York at Buffalo

Conditions

Musculoskeletal PainStomatognathic DiseasesTooth DiseasesTooth, Impacted

Phase 3

Ibuprofen Liquid Capsules 2 x 200 mg Efficacy and PK/PD Study in Surgical Removal of Impacted Third Molars

CompletedNCT05484401

Reckitt Benckiser Healthcare (UK) LimitedStomatognathic Diseases, Tooth Diseases, Tooth, Impacted

Start: 2022-08-09End: 2023-06-15Updated: 2023-06-22

Phase 4

Musculoskeletal Outcomes Using Tylenol/Ibuprofen vs. Oral Steroids in New Injuries

Enrolling by invitationNCT07393503

State University of New York at BuffaloMusculoskeletal Pain

Start: 2025-09-17End: 2027-01-01Target: 60Updated: 2026-02-18